NBD AI Bulletin - Humanwell Healthcare (Group) (the Company, SH 600079, close price: 26.78 yuan) announced on February 8 that the Company's board of directors has received a written resignation letter from Mr. Xu Huabin, vice president of the Company. Mr. Xu Huabin, for personal reasons, has offered to resign as vice president of the Company, and the resignation took effect upon the delivery of the resignation letter to the board. Mr. Xu Huabin will no longer hold any position in the Company, and his resignation will not make impact on the Company's governance, daily management, operations and credit capacity.

The 2019 annual report shows that Humanwell Healthcare (Group) mainly engages in pharmaceutical wholesale, medicine, other business, accounting for 54.23%, 44.57%, 0.84% of its revenue, respectively.

Humanwell Healthcare (Group)'s chairman is Li Jie, male, 66 years old, undergraduate, senior engineer. The president of Humanwell Healthcare (Group) is Deng Xiafei, male, 58, Ph.D of engineering from Beijing University of Technology.

Tips on "Stock Trends":

1. The number of shares held by northbound investors in the Company increased by 6.9818 million over the past 30 days, representing 0.52% of the Company's circulating shares;

2. There was no institutional research on the Company in the past 30 days.

3. The most recent personnel change announcement of the Company was made on April 30, 2020. The Company released a total of 9 such announcements in the past 12 months.

(By Lan Suying)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.